Meriem Jones

Meriem Jones

Auto-generated profile, based on publicly available information

Meriem Jones

Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2015 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MJM. Jerbi
M. Jerbi
MRM. Ben Rekaya
M. Ben Rekaya
CNC. Naouali
C. Naouali
MJM. Jones
M. Jones
OMO. Messaoud
O. Messaoud
HYHouda Yacoub-Youssef
Houda Yacoub-Youssef

11 January 2012 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
ABAlmut Böer-Auer
Almut Böer-Auer
MJMeriem Jones
Meriem Jones
OLOlesya V. Lyasnichaya
Olesya V. Lyasnichaya

1 January 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MRMariem Ben Rekaya
Mariem Ben Rekaya
MJManel Jerbi
Manel Jerbi
OMOlfa Messaoud
Olfa Messaoud
ABAhlem Sabrine Ben Brick
Ahlem Sabrine Ben Brick
MZMohamed Zghal
Mohamed Zghal
SASonia Abdelhak
Sonia Abdelhak
Xeroderma Pigmentosum(XP) is a rare recessive autosomal cancer prone disease, characterized by UV hypersensitivity and early appearance of cutaneous and ocular malignancies. We investigated four unrelated patients suspected to be XP-C. To confirm linkage toXPCgene, genotyping and direct sequencing ofXPCgene were performed. Pathogenic effect of novel mutations was confirmed by reverse Transciptase PCR. Mutation screening revealed the presence of two novel mutations g.18246G>A and g.18810G>T in theXPCgene (NG_011763.1). The first is present in one patient XP50NEF, but the second is present in three unrelated patients (XP16KEB, XP28SFA, and XP45GB). These 3 patients are from three different cities of Southern Tunisia and bear the same haplotype, suggesting a founder effect. Reverse Transciptase PCR revealed the absence of theXPCmRNA. In Tunisia, as observed in an other severe genodermatosis, the mutational spectrum of XP-C group seems to be homogeneous with some clusters of heterogeneity that should be taken into account to improve molecular diagnosis of this disease.

23 June 2011 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
IZInès Zaraa
Inès Zaraa
MJMeriem Jones
Meriem Jones
STSondes Trojjet
Sondes Trojjet
RRRym Cheikh Rouhou
Rym Cheikh Rouhou
DEDalenda El Euch
Dalenda El Euch
AOAmel Ben Osman
Amel Ben Osman

8 September 2015 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
JTJuan Carlos Hiromi López Takegami
Juan Carlos Hiromi López Takegami
MWManfred Wolter
Manfred Wolter
CLChristoph Löser
Christoph Löser
CMCorinna Maiweg
Corinna Maiweg
MJMeriem Jones
Meriem Jones
ABAlmut Böer‐Auer
Almut Böer‐Auer

14 February 2019 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
ACAsma Chikhaoui
Asma Chikhaoui
SESahar Elouej
Sahar Elouej
INImen Nabouli
Imen Nabouli
MJMeriem Jones
Meriem Jones
ALArnaud Lagarde
Arnaud Lagarde
HYHouda Yacoub-Youssef
Houda Yacoub-Youssef
Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder due to a defect in the nucleotide excision repair (NER) DNA repair pathway, characterized by severe sunburn development of freckles, premature skin aging, and susceptibility to develop cancers at an average age of eight. XP is an example of accelerated photo-aging. It is a genetically and clinically heterogeneous disease. Eight complementation groups have been described worldwide. In Tunisia, five groups have been already identified. In this work, we investigated the genetic etiology in a family with an atypically mild XP phenotype. Two Tunisian siblings born from first-degree consanguineous parents underwent clinical examination in the dermatology department of the Charles Nicolle Hospital on the basis of acute sunburn reaction and mild neurological disorders. Blood samples were collected from two affected siblings after written informed consent. As all mutations reported in Tunisia have been excluded using Sanger sequencing, we carried out mutational analysis through a targeted panel of gene sequencing using the Agilent HaloPlex target enrichment system. Our clinical study shows, in both patients, the presence of achromic macula in sun exposed area with dermatological feature suggestive of Xeroderma pigmentosum disease. No developmental and neurological disorders were observed except mild intellectual disability. Genetic investigation shows that both patients were carriers of an homozygous T to C transition at the nucleotide position c.2333, causing the leucine to proline amino acid change at the position 778 (p.Leu778Pro) of the ERCC5 gene, and resulting in an XP-G phenotype. The same variation was previously reported at the heterozygous state in a patient cell line in Europe, for which no clinical data were available and was suggested to confer an XP/CS phenotype based on functional tests. This study contributes to further characterization of the mutation spectrum of XP in consanguineous Tunisian families and is potentially helpful for early diagnosis. It also indicates that the genotype-phenotype correlation is not always coherent for patients with mild clinical features. These data therefore suggest that targeted NGS is a highly informative diagnostic strategy, which can be used for XP molecular etiology determination.